preeclampsia | GenomeWeb

preeclampsia

This Week in PNAS

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

Using absolute and relative gene expression analyses, researchers identified expression patterns associated with preeclampsia in dozens of placental tissue samples.

The money will be used to complete development of the preeclampsia test PrePsia and to commercialize an in-licensed metabolomic biomarker technology.

Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.

The prospective study found the markers were able to rule out a woman's chance of developing preeclampsia with a negative predictive value of 99.3 percent.

Members of the small hunter-gatherer group from sub-Saharan Africa carry killer-cell immunoglobulin-like receptor alleles that appear to alter immune function in ways that benefit pregnancy.

A spin-out ofStanfordUniversity, Carmenta is focused on developing a test for preeclampsia, a hypertensive disorder of pregnancy.

A spin-out of Stanford University, Carmenta is focused on developing a test for preeclampsia, a hypertensive disorder of pregnancy.

The Irish firm said its test can differentiate pre-eclampsia from other maternal disorders. 

NEW YORK (GenomeWeb) – Alnylam Pharmaceuticals this month announced that it has expanded its pipeline to include ALN-AGT, a subcutaneously administered treatment for preeclampsia and other pregnancy-associated hypertensive disorders.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.